Aquestive Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $121.2M | $71.5M | $23.9M | $27.3M | $28.0M | $31.8M | $49.3M | $60.6M |
| Accounts Receivable | $17.8M | $7.3M | $8.5M | — | — | — | — | — |
| Inventory | $6.2M | $6.0M | $6.8M | $5.8M | $4.0M | $2.5M | $2.9M | $5.4M |
| Total Current Assets | $149.3M | $88.2M | $41.0M | $39.9M | $47.3M | $44.6M | $68.3M | $74.2M |
| Property, Plant & Equipment | $3.9M | $3.8M | $4.2M | $4.1M | $5.1M | $6.9M | $9.7M | $12.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $0 | $0 | $1.3M | $1.4M | $51.0K | $102.0K | $153.0K | $204.0K |
| Total Assets | $160.4M | $101.4M | $57.4M | $57.1M | $62.0M | $62.9M | $78.5M | $86.9M |
| Liabilities | ||||||||
| Accounts Payable | $29.9M | $10.3M | $8.9M | $9.9M | $8.3M | $7.1M | $12.3M | $20.4M |
| Total Current Liabilities | $47.6M | $18.9M | $18.3M | $39.5M | $22.0M | $21.1M | $18.6M | $33.0M |
| Long-Term Debt | $45.0M | $45.0M | $45.0M | $33.4M | — | $51.5M | $70.0M | — |
| Total Liabilities | $194.1M | $161.6M | $163.9M | $175.6M | $144.1M | $111.4M | $84.6M | $76.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-447.0M | $-363.2M | $-319.1M | $-311.2M | $-256.8M | $-186.3M | $-130.5M | $-61.4M |
| Total Stockholders' Equity | $-33.7M | $-60.2M | $-106.5M | $-118.6M | $-82.1M | $-48.5M | $-6.1M | $10.1M |